JP Morgan Chase’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-100
Closed -$9.04K – 7698
2026
Q1
$9.04K Buy
+100
New +$8.86K ﹤0.01% 6769

Other funds holding ACLS

JP Morgan Chase's ACLS Position: Q3 2026 in Review

JP Morgan Chase increased its Axcelis (ACLS) stake by 6.2% in Q3 2026, buying an estimated $348K and bringing the position to 46,728 shares worth $6.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3286.

JP Morgan Chase first reported a position in ACLS in Q2 2013 and has held it in 47 quarters since. The position peaked at $73.2M in Q4 2023. 262 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • JP Morgan Chase held 46,728 shares of Axcelis worth $6.23M as of Q3 2026.
  • JP Morgan Chase bought 2,717 Axcelis shares in Q3 2026, an estimated $348K.
  • Axcelis made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #3286 holding.
  • JP Morgan Chase first reported a position in Axcelis in Q2 2013 and has held it in 47 quarters since.
  • JP Morgan Chase's Axcelis position peaked at $73.2M in Q4 2023.
  • 262 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.